Diagnosis and management of acromegaly: the patient’s perspective
- 7 January 2016
- journal article
- research article
- Published by Springer Nature in Pituitary
- Vol. 19 (3) , 268-276
Abstract
Purpose Early diagnosis is a success factor for the prevention of long-term comorbidity and premature death in patients with acromegaly, but large-scale data on the diagnostic process and disease management are scarce. Therefore, we aimed to evaluate the diagnostic process, implementation of treatment and changes in life situation in patients with acromegaly, focusing on sex-specific differences. Methods Non-interventional patient-reported outcome study. 165 patients with clinically and biochemically proven acromegaly were questioned about the diagnostic process and utilization of health care by means of a self-developed standardized postal survey including questions on acromegaly symptoms experienced before diagnosis, number and specialty of consulted doctors, time to diagnosis and aftercare. Results The diagnostic process took 2.9 (SD 4.53) years, during which 3.4 (SD 2.99) physicians were consulted. Women waited longer [4.1 (SD 5.53) years] than men [1.6 (SD 2.69) years; p = 0.001] for the correct diagnosis, and consulted more doctors in the process [4.0 (SD 2.99) vs. 2.7 (SD 2.84) doctors, p < 0.001, respectively]. In 48.5 % of patients, acromegaly was diagnosed by an endocrinologist (men: 45.1 %; women: 52.4 %). Overall disease duration from symptom onset until last surgery was 5.5 (SD 6.85) years, with no sex differences. A change in employment status was the most commonly reported event after diagnosis and a quarter of the patients stated that the illness had changed their lives. Conclusions Our findings confirm the urgent need to increase awareness of the clinical manifestation of acromegaly to facilitate an earlier diagnosis of the disease and to provide diagnostic equality across the sexes.Keywords
Funding Information
- Ipsen Pharma GmbH, Germany
This publication has 32 references indexed in Scilit:
- MANAGEMENT OF ENDOCRINE DISEASE: GH excess: diagnosis and medical therapyEuropean Journal of Endocrinology, 2014
- Emerging trends in the diagnosis and treatment of acromegaly in CanadaClinical Endocrinology, 2013
- The Metabolic Profile in Active Acromegaly is Gender-SpecificThe Journal of Clinical Endocrinology & Metabolism, 2013
- Clinical Manifestations and Diagnosis of AcromegalyInternational Journal of Endocrinology, 2012
- Clinical, quality of life, and economic value of acromegaly disease controlPituitary, 2011
- Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under‐recognized and under‐diagnosedClinical Endocrinology, 2010
- German health care: a bit of Bismarck plus more scienceBMJ, 2008
- Mortality in Acromegaly: A MetaanalysisThe Journal of Clinical Endocrinology & Metabolism, 2008
- Determining the Need for Hip and Knee Arthroplasty: The Role of Clinical Severity and Patients??? PreferencesMedical Care, 2001
- Determinants of clinical outcome and survival in acromegalyClinical Endocrinology, 1994